Recently, emerging studies in DMD patients and animal models have indicated that DMD progression is not fully explained by sarcolemma fragility which was attributed to the absence of dystrophin, aberrant expression of many other genes candidated for many other impaired spectrums also play crucial roles in the development of DMD [12, 13]. Here, DMD is linked to Duchenne muscular dystrophy.